Skip to main content
Premium Trial:

Request an Annual Quote

454 Launches Automation Module for Emulsion PCR Enrichment


Roche's 454 Life Sciences said this week that it is launching a module for liquid-handling systems to automate a step in the sample preparation for its Genome Sequencer FLX.

The company said that the REM e System, a robotic accessory module that works with several liquid handling platforms, automates the enrichment step of emulsion PCR and subsequent primer hybridization in the GS FLX Titanium series workflow, replacing up to five hours of "dedicated manual lab work."

The module, which is available immediately, automates the last step of emPCR, which consists of amplification, emulsion breaking, and bead enrichment. It works with liquid workstations such as the Hamilton STARlet, Hamilton Star, Tecan Genesis RSP 100, and Biomek FX.

The REM e System supports up to four sequencing runs a day, is compatible with several emulsion volumes, and works with a variety of sequencing libraries, including shotgun, paired-end, cDNA, amplicon libraries, and libraries with barcoded samples.

454 said that the REM e System represents "one of a series of recent improvements to streamline the sequencing system's end-to-end workflow." Other recent improvements include a new library preparation kit, which is faster than previous kits and requires less DNA; and upgrades to the GS FLX's data analysis software (see In Sequence 9/29/2009).

With the new module, 454 addresses one of the most frequent complaints of users of 454's GS FLX as well as Applied Biosystems' SOLiD system, both of which amplify DNA using emulsion PCR. Users have described this process as time-consuming and labor-intensive.

The Scan

Panel Votes for COVID-19 Pill

A US Food and Drug Administration panel has voted to support the emergency use authorization of an antiviral pill for COVID-19 from Merck and Ridgeback Biotherapeutics, CNN says.

But Not Harm

New Scientist reports that UK bioethicists say that though gene editing may improve food production, it should not harm livestock welfare.

Effectiveness Drop Anticipated

Moderna's Stéphane Bancel predicts that that current SARS-CoV-2 vaccines may be less effective against the Omicron variant, the Financial Times reports.

Cell Studies of Human Chromatin Accessibility, SARS-CoV-2 Variants, Cell Signaling Networks

In Cell this week: chromatin accessibility maps of adult human tissues, modeling to track SARS-CoV-2 variants of concern, and more.